Please use this identifier to cite or link to this item:
http://localhost:80/xmlui/handle/123456789/13266
Title: | Volatile constituents and in vitro activity of Syzygium aromaticum flower buds (clove) against human cancer cell lines |
Authors: | Sara, Sara Begum, Sabira Nawazish Ali, Syed Dar Farooq, Ahsana Faheema Siddiqui S Siddiqui, Bina Ayub, Anjum Fatima, Mashhad |
Keywords: | Cytotoxicity growth inhibition Syzygium aromaticum eugenol GC-MS sulforhodamine-B |
Issue Date: | 26-Nov-2020 |
Publisher: | Karachi:Faculty of Pharmacy, University of Karachi |
Citation: | Begum, S., Ali, S. N., Farooq, A. D., Siddiqui, F., Siddiqui, B. S., Ayub, A., & Fatima, M. (2020). Volatile constituents and in vitro activity of Syzygium aromaticum flower buds (clove) against human cancer cell lines. Pakistan Journal of Pharmaceutical Sciences, 33(6). |
Abstract: | The methanolic extract (SA-EXT) of Syzygium aromaticum flower buds and its fractions tested against three human cancer cell lines viz uterine cervix (HeLa), breast (MCF-7) and lung NCI (H-460) using sulforhodamine-B assay. The ethyl acetate soluble sub fraction (SA-EAS) was active only against HeLa cells with GI50value of 36± 3.4µg/mL. The most active sub-fraction (SA-PES-Fr-2) showed growth inhibition (GI50: 36, 50 and 68µg/ml against MCF-7, HeLa and NCI-H-460 cancer cell lines, respectively) with cytotoxic effect LC50= 88 ± 3.4 µg/mL against HeLa and LC50=86 ± 2.8 µg/mL against MCF-7. The most active sub-fraction (SA-PES-Fr-2) analyzed by GC and GC-MS techniques revealed that eugenol was most abundant (85.34%) along with minor constituents. Thus it can be concluded that growth inhibitory and cytotoxic effect residing in Syzygium aromaticum flower buds (clove) is more likely due to eugenol. |
URI: | http://142.54.178.187:9060/xmlui/handle/123456789/13266 |
ISSN: | 1011-6011X |
Appears in Collections: | Issue 6 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Paper-26.htm | 131 B | HTML | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.